Pancreatic Cancer Research

ResearcherUniversity of DundeeActive in the last 2 years

Douglas J.A. Adamson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4026-1593; OpenAlex author ID A5087951378. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. PPARδ Expression and Prognosis in Resected Pancreatic Cancer: A Retrospective Single-Centre Study Co-author DOI 10.64898/2026.09.08.750098↗
  2. Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer. Co-author DOI 10.1038/bjc.2016.271↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Iain Stephen Tait · 1 shared paper, 2026 · strength 0.43
  2. Colin Neil Alexander Palmer · 1 shared paper, 2026 · strength 0.43
  3. Andrés Jesús Muñoz Martín · 1 shared paper, 2016 · strength 0.04
  4. Satvinder Mudan · 1 shared paper, 2016 · strength 0.04
  5. Justin Stebbing · 1 shared paper, 2016 · strength 0.04
  6. Demetris Papamichael · 1 shared paper, 2016 · strength 0.04
  7. Ray McDermott · 1 shared paper, 2016 · strength 0.04
  8. Angus George Dalgleish · 1 shared paper, 2016 · strength 0.04
  9. Robert Díaz Beveridge · 1 shared paper, 2016 · strength 0.04
  10. Roberto Pazo-Cid · 1 shared paper, 2016 · strength 0.04
  11. David Kuang-Fu Chang · 1 shared paper, 2016 · strength 0.04
  12. Alberto Zaniboni · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.